| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/09/2007 | US7279560 Administering monoclonal antibodies to inhibit transmission of costimulatory signal of lymphocytes; antiallergens; autoimmune diseases |
| 10/09/2007 | US7279558 The protein encoded by novel gene has two WW domains that participate in protein interactions in the N-terminal domain, and this protein binds to other proteins, thus regulates the intracellular signal transduction, gene expression |
| 10/09/2007 | US7279557 Therapeutic and diagnostic agents |
| 10/09/2007 | US7279552 Pro1782 polypeptides |
| 10/09/2007 | US7279464 For immunizing a mammal against cancer cells that present a carcinoembryonic antigen (CEA) |
| 10/09/2007 | US7279463 A gene therapy using a single strand oligonucleotide to form a triple stranded nucleic acid with a target double stranded nucleic acid, hybridization to form a mutant |
| 10/09/2007 | US7279462 Administering to a lymphoid tissue in vivo a plasmid vector containing a nucleic acid molecule comprising a B cell specific expression element operationally linked to a nucleic acid sequence encoding one or more heterologous epitopes |
| 10/09/2007 | US7279336 Methods and compositions for enhanced plant cell transformation |
| 10/09/2007 | US7279335 Purification of coat protein of lettuce big-vein virus (LBVV), its amino acid sequences determination, cloning by polymerase chain reaction using primers designed based on the determined amino acid sequences information, structure elucidation |
| 10/09/2007 | US7279334 Increasing recombination between homologous chromosomes in a dividing cell by introducing a nucleic acid sequence encoding a fusion protein having a DNA binding domain that recognizes a DNA sequence in the chromosomes linked to a Spo11 protein, and having the cell divide |
| 10/09/2007 | US7279333 Virus envelope vector for gene transfer |
| 10/09/2007 | US7279331 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders |
| 10/09/2007 | US7279329 Expression system for producing collagen |
| 10/09/2007 | US7279327 Methods for producing recombinant coronavirus |
| 10/09/2007 | US7279326 composition for delivering a wild-type mitochondrial DNA molecule to a mammalian cell, comprising: a wild-type mammalian mitochondrial DNA molecule having a mitochondrial leader sequence peptide attached to facilitate uptake into the cell; gene therapy of conditions caused by mitochondrial DNA defect |
| 10/09/2007 | US7279325 Comprises peptide which demonstrates ligand dependent transcriptional activity when fused to DNA binding domain; mimetics; regulatory sequences; transcriptional control |
| 10/09/2007 | US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif |
| 10/09/2007 | US7279322 Electrospraying apparatus and method for coating particles |
| 10/09/2007 | US7279321 Enhancing yield of aromatic carboxylic acids in enteric bacteria via transforming, propagating and fermentation with operon coding transport protein |
| 10/09/2007 | US7279318 Reacting the elements such as viruses and other micro-organisms with a synthetic hydrophilic multivalent polymer with a backbone based upon monomer units of N-2-hydroxypropylmethacrylamide, N-(2-Hydroxy ethyl)-L-Glutamine, ethyleneglycol-oligopeptide or dextran monomers and multiple reactive groups |
| 10/09/2007 | US7279315 Polypeptides having glucanotransferase activity and nucleic acids encoding same |
| 10/09/2007 | US7279313 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 10/09/2007 | US7279312 Using probes/primers of mutant microsatellite nucleotide sequence to diagnose/prognose cell proliferative disorders of lung, head and neck |
| 10/09/2007 | US7279310 having a beta 1,3-N-acetylglucosaminyltransferase activity; for diagnosis and treatment for inflammatory diseases, cancer or tumor metastasis |
| 10/09/2007 | US7279308 Nucleotide sequences coding hydrolase for generating protein hydrolysates useful as flavour improving agents; food processing |
| 10/09/2007 | US7279307 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18 |
| 10/09/2007 | US7279306 Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof |
| 10/09/2007 | US7279305 Gene, disrupted in schizophrenia |
| 10/09/2007 | US7279302 Methods for identifying herbicidal compounds |
| 10/09/2007 | US7279299 Contacting a candidate molecule with a polypeptide, Polypeptide retains the ability to dephosphorylate an activated MAP-kinase; detecting the presence or absence of binding of the candidate molecule to the polypeptide, and determining whether the candidate molecule interacts with the DSP-10 polypeptide |
| 10/09/2007 | US7279298 has an activity to release side chain carboxyl groups and ammonia from a protein by acting upon side chain amido groups in the protein |
| 10/09/2007 | US7279293 Constitutively active histamine H3 receptor mutants and uses thereof |
| 10/09/2007 | US7279284 Steroid hormone binding protein |
| 10/09/2007 | US7279279 Contacting a cell with a viral particle in the presence of compound, detecting the expression of indicator gene, comparing the expression detected and a control expression of indicator gene, thereby determining the susceptibility of HIV to compound |
| 10/09/2007 | US7279278 Preparing expression vector via obtaining blunt ended nucleotide sequence, ligating, amplifying, recovering and religating amplification products |
| 10/09/2007 | US7279277 Identifying fetal cell nuclei, chromosomes or DNA in a maternal blood or vaginal sample; detecting chromosomal aberrations |
| 10/09/2007 | US7279171 Containing an immunogenic amount of a C. psittaci major outer membrane protein (MOMP) polypeptide lacking regions VD1 and VD2; nucleic acid vectors for the expression of MOMP polypeptides and MOMP polypeptide fusion proteins; immunization |
| 10/09/2007 | US7279170 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis |
| 10/09/2007 | US7279166 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 10/09/2007 | US7279164 Chimeric proteins that induce effects directed against viruses |
| 10/09/2007 | US7279161 Treating patients afflicted with hemophilia A by administering an antibody that binds factor IX/factor IXa and increases the procoagulant activity of FIXa |
| 10/09/2007 | US7279159 Nucleic acids; fusion proteins; binding to endothelial growth factor; fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
| 10/09/2007 | US7279157 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease |
| 10/09/2007 | CA2327261C Nicotianamine synthase and gene encoding the same |
| 10/09/2007 | CA2294579C Liposome-entrapped polynucleotide composition and method |
| 10/09/2007 | CA2257115C Spruce budworm antifreeze proteins, genes and methods of using same |
| 10/09/2007 | CA2181266C Methods for the elimination of dna sequencing artifacts |
| 10/09/2007 | CA2158544C Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 10/09/2007 | CA2156416C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 10/09/2007 | CA2099503C Synthetic alpha-l-iduronidase and genetic sequences encoding same |
| 10/09/2007 | CA1341556C Effecting somatic changes in plants through the use of negative strand rnas |
| 10/09/2007 | CA1341554C Neuronal nicotinic acetylcholine receptor compositions and assay |
| 10/05/2007 | CA2646021A1 O-glycans in the treatment of inflammatory bowel disease and cancers |
| 10/04/2007 | WO2007112326A1 Promoter, promoter control elements, and combinations, and uses thereof |
| 10/04/2007 | WO2007112299A2 Enzymatic preparation of (s) amino acid from (r,s) amino acid or from keto acid |
| 10/04/2007 | WO2007112107A2 Synthetic lipid rafts and methods of use |
| 10/04/2007 | WO2007112051A2 Polypyrimidine-tract binding protein (ptb) as a biomarker and target for the diagnosis and treatment of cancer |
| 10/04/2007 | WO2007112011A2 Compositions and methods for generating transgenic animals |
| 10/04/2007 | WO2007112005A2 Pc5 as a factor ix propeptide processing enzyme |
| 10/04/2007 | WO2007111998A2 Dsrna compositions and methods for treating hpv infection |
| 10/04/2007 | WO2007111496A1 Improved carbohydrate recognition domains |
| 10/04/2007 | WO2007111333A1 Method of reducing cell injury in nucleic acid transfection |
| 10/04/2007 | WO2007111324A1 Method of detecting 5-methylcytosine in gene and detection kit |
| 10/04/2007 | WO2007111275A1 Method for inhibiting signal transduction, signal transduction inhibitor to be used therein and use thereof |
| 10/04/2007 | WO2007111274A1 Nucleic acid detection cassette and nucleic acid detection apparatus |
| 10/04/2007 | WO2007110632A1 Bacterial vaccine |
| 10/04/2007 | WO2007110628A2 Compositions and methods for therapy of cystic fibrosis |
| 10/04/2007 | WO2007110623A2 Screening method |
| 10/04/2007 | WO2007110619A1 Beta-galactosidase with transgalactosylating activity |
| 10/04/2007 | WO2007110608A2 Fermentation process for the production of ethanol |
| 10/04/2007 | WO2007110606A1 Enhancement of microbial ethanol production |
| 10/04/2007 | WO2007110600A2 Plant promoters, coding sequences and their uses |
| 10/04/2007 | WO2007110341A1 Method for preparing differentiated avian cells and genes involved in maintaining pluripotency |
| 10/04/2007 | WO2007110314A2 Proteins associated with abiotic stress response and homologs |
| 10/04/2007 | WO2007110245A1 Animal model based on targeted apoptosis for the study of genetic diseases such as parkinson's disease |
| 10/04/2007 | WO2007110210A2 Angiomotin sirna molecules and uses thereof |
| 10/04/2007 | WO2007110098A1 HBx PEPTIDES, CAPABLE OF ELICITING A PROMISCUOUS IMMUNODOMINANT CD4+ RESPONSE DIRECTED AGAINST HBV |
| 10/04/2007 | WO2007109908A1 Therapeutic yb-1 phosphorylation decoys |
| 10/04/2007 | WO2007109823A2 Peptide library |
| 10/04/2007 | WO2007094003A3 Viral display vehicles for treating multiple sclerosis |
| 10/04/2007 | WO2007092777A3 Cloning, characterization, and application of tnfrsf19 in neurological disorders |
| 10/04/2007 | WO2007088371A3 Expression system |
| 10/04/2007 | WO2007084767A3 Methods for profiling transcriptosomes |
| 10/04/2007 | WO2007082734A3 Influenza vaccine |
| 10/04/2007 | WO2007075976A3 Method of producing biologically active vitamin k dependent proteins by recombinant methods |
| 10/04/2007 | WO2007071820A9 Novel enzymes |
| 10/04/2007 | WO2007071422A3 Pharmaceutical antibody compositions with resistance to soluble cea |
| 10/04/2007 | WO2007062380A3 Modulation of eif4e-bp2 expression |
| 10/04/2007 | WO2007057781A3 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof. |
| 10/04/2007 | WO2007054816A3 Antibody ultrahumanization by predicted mature cdr blasting and cohort library generation and screening |
| 10/04/2007 | WO2007053542A3 Methods and compositions for the prevention and regression of neovascularization |
| 10/04/2007 | WO2007047995A3 Modified proteases that inhibit complement activation |
| 10/04/2007 | WO2007046006A3 Il-15ralpha sushi domain as a selective and potent enhancer of il-15 action through il-15rbeta/gamma, and hyperagonist (ilralpha sushi-il 15) fusion proteins |
| 10/04/2007 | WO2007044886A3 Methods to produce desired proteins in plants |
| 10/04/2007 | WO2007044362A3 Allele-specific rna interference |
| 10/04/2007 | WO2007042289A3 Nanobodies™ and polypeptides against egfr and igf-ir |
| 10/04/2007 | WO2007041350A3 Regulatable fusion promoters |
| 10/04/2007 | WO2007035771A3 Modulation of glucagon receptor expression |
| 10/04/2007 | WO2007030619A3 Pharmaceutical compositions for delivery of ribonucleic acid to a cell |
| 10/04/2007 | WO2007030014A3 Homologous recombination in plants |